The Starr Foundation’s sixth Starr Cancer Consortium (SCC) Grant Competition awarded $5 million to 5 cancer research teams focusing on discovering new cancer mechanisms related to genetic mutations or epigenetic involvement in a variety of cancers. The awards were given to the following 5 teams for these projects:
“This Consortium has launched a number of innovative, collaborative cancer research projects that are already linking discoveries in the laboratory to the clinic. Better patient outcomes are our ultimate goal, and we see progress every year,” said Florence A. Davis, President of the Starr Foundation. Weill Cornell Medical College; February 1, 2013